Material: Crystal

Medicinal Cannabis Deal Toy

Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.

(20ALJ334)
2 Images
Custom financial tombstone commemorating the ipo of New Zealand-based medicinal cannabis firm Rua Bioscience.

Logo-Themed Medtech Deal Toy

Logo-themed deal toy commemorating a private placement by Viveve. The Colorado-based medical technology company specializes in women’s health.

(20AJH071)
1 Image

Bank Acquisition Financial Tombstone

Crystal financial tombstone commemorating the acquisition by Bangkok Bank of Indonesian lender Bank Permata. The sellers were Standard Chartered and Astra International.

(20AKL191)
1 Image

Heart-Themed Crystal Deal Tombstone

Crystal deal tombstone celebrating the acquisition of Mlinar, a Croatia-based bakery retail chain. The purchaser, Mid Europa Partners, a private equity firm operating in Central and Eastern Europe.

(9LSS186)
1 Image

Pancake-Themed Merger Commemorative

Custom crystal celebrating the merger of Honey-Jam Café and Butterfields. Both restaurant brands specialize in breakfast, brunch, and lunch menus.

(9AMF363)
1 Image

Solar Plant Groundbreaking Commemorative

Custom crystal commemorative celebrating the beginning of construction of the Michael C. Whiteside Solar Electric Plant. The facility will be located in Heard County, Georgia.

(20AMF047)
1 Image

ESPN Crystal Leadership Award

Billie Jean King Youth Leadership Award presented to Joel Apudo at the 2020 ESPN Espy Awards ceremony. Apudo manages a youth soccer program in the West End neighborhood of Atlanta.

(20AKL184)
1 Image

Pirate Ship-Themed Deal Toy

Code name-themed crystal deal toy celebrating two acquisitions by Americold, a real estate investment trust (REIT) specializing in temperature-controlled warehouses. The  two cold storage facilities are located in Pennsylvania and Maryland.

(20AJH101)
1 Image

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.